helping hematologists conquer blood diseases
About ASH | Patients | Media | Make a Gift | Corporate Supporters
Home > Education > Teach case > Broudy >
  E-Mail This Page | Print This Page
MembershipMeetingsPublicationsEducation & CareersPolicy & PracticeASH Store


Find a Hematologist
Hematology Library

Blood
Image Bank
Education Program Book
ASH-SAP
Abstract Search
 
Teaching Cases

Polycythemia — Virginia C. Broudy, MD
University of Washington School of Medicine, Seattle, WA

Copyright of the American Society of Hematology, 2006. ISSN: 1931-6860.


I. HistoryII. Physical ExamIII. Laboratory DataIV. Differential Diagnosis
V. PathophysiologyVI. Prognosis/Clinical CourseVII. Teaching PointsVIII. Bibliography

VII. TEACHING POINTS

The three pathophysiologic categories of polycythemia are:
  • Relative polycythemia (red blood cell mass normal; plasma volume decreased)
  • Secondary polycythemia (red blood cell mass increased)
  • Polycythemia vera (red blood cell mass increased)

Comparison of Polycythemia Vera and Secondary Polycythemia
  Polycythemia Vera Secondary Polycythemia
Pathophysiology Neoplastic hematopoietic stem cell disorder Due to tissue hypoxia causing an appropriate increase in Epo production, or to renal or hepatic disease causing an inappropriate increase in Epo production
CBC Hct and often WBC and platelets are increased Only Hct is increased
Epo level Decreased or low normal Normal or increased
Treatment Phlebotomy and/or hydroxyurea to keep Hct below 46% (men) or below 43% (women); most patients should also take aspirin 81 mg daily to decrease the risk of thrombosis. Treatment is usually not required

View Bibliography

Have a question or comment about the ASH Teaching Cases? Please e-mail webmaster@hematology.org.

 

 

Contact Us   |   Terms of Use   |   Photo Credit   |   RSS

1900 M Street, NW, Suite 200    Washington, DC 20036    Phone: 202-776-0544    Fax: 202-776-0545    E-mail: ash@hematology.org

©2008 American Society of Hematology